>
Patheon NV logo

PTHN - Patheon NV Share Price

$34.98 0.0  0.0%

Last Trade - 01/09/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £1.37bn
Position in Universe th / 6917
Bullish
Bearish
Unlock PTHN Revenue
Momentum
Relative Strength (%)
1m -2.01%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Oct 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
697.6 748 1,020 1,484 1,774 1,867 2,009 2,208 +21.8%
+31.7 +149.6 +29.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 April 2017, Patheon NVrevenues increased 8% to $940.8M. Net income beforeextraordinary items totaled $55.9M vs. loss of $18.1M.Revenues reflect DPS segment increase of 99% to $572.4M,DSS segment increase from $127.9M to $259.1M, United Statessegment increase of 84% to $583.9M, Europe segment increasefrom $124.8M to $300.6M. Net Income reflects InterestExpense, Net decrease of 32% to $59M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PTHN Revenue Unlock PTHN Revenue

Net Income

PTHN Net Income Unlock PTHN Revenue

Normalised EPS

PTHN Normalised EPS Unlock PTHN Revenue

PE Ratio Range

PTHN PE Ratio Range Unlock PTHN Revenue

Dividend Yield Range

PTHN Dividend Yield Range Unlock PTHN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PTHN EPS Forecasts Unlock PTHN Revenue
Profile Summary

Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company's segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products. The PDS segment provides a range of formulation, production and technical services from the early stages of a product's development to regulatory approval, as well as for new formulations of approved products for lifecycle extension. The DSS segment provides small molecule active pharmaceutical ingredient (API) and outsourced manufacturing solutions for large molecule biological API from early development through commercial scale production. It provides an integrated range of API and finished drug product services to its customers, from formulation development to clinical and commercial-scale manufacturing.

Directors
Last Annual October 31st, 2016
Last Interim April 30th, 2017
No. of Shareholders: n/a
No. of Employees: 9,100
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange New York Stock Exchange
Shares in Issue 145,136,214
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PTHN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PTHN
Upcoming Events for PTHN
Frequently Asked Questions for Patheon NV
What is the Patheon NV share price?

As of 01/09/17, shares in Patheon NV are trading at $34.98, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Patheon NV share price performed this year?

Shares in Patheon NV are currently trading at $34.98 and the price has moved by 25.06% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Patheon NV price has moved by -9.71% over the past year.

What are the analyst and broker recommendations for Patheon NV?

Of the analysts with advisory recommendations for Patheon NV, there are there are currently 0 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Patheon NV is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Patheon NV next release its financial results?

Patheon NV is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-04-30
What is the Patheon NV dividend yield?

Patheon NV does not currently pay a dividend.

Does Patheon NV pay a dividend?

Patheon NV does not currently pay a dividend.

When does Patheon NV next pay dividends?

Patheon NV does not currently pay a dividend.

How do I buy Patheon NV shares?

To buy shares in Patheon NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Patheon NV?

Shares in Patheon NV are currently trading at $34.98, giving the company a market capitalisation of £n/a.

Where are Patheon NV shares listed? Where are Patheon NV shares listed?

Here are the trading details for Patheon NV:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: PTHN
What kind of share is Patheon NV?

We were not able to load our ranking data for Patheon NV

Is there a Patheon NV share price forecast 2021?

We were not able to load any forecast data for Patheon NV.

How can I tell whether the Patheon NV share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Patheon NV. Over the past six months, the relative strength of its shares against the market has been -5%. At the current price of $34.98, shares in Patheon NV are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Patheon NV PE Ratio?

We were not able to find PE ratio data for Patheon NV.

Who are the key directors of Patheon NV?

We were unable to find the directors for Patheon NV.

Who are the major shareholders of Patheon NV?

Here are the top five shareholders of Patheon NV based on the size of their shareholding:

Similar to PTHN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.